ICD-10-CM 2020 Search includes the entire 2020 code set for diagnostic coding in an easily searched always accessible web based platform.

Displaying 36101 - 36200 of 73384
Title
T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
T46.7X5S Adverse effect of peripheral vasodilators, sequela
T46.7X6A Underdosing of peripheral vasodilators, initial encounter
T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter
T46.7X6S Underdosing of peripheral vasodilators, sequela
T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T46.8X1D Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
T46.8X1S Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
T46.8X2A Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T46.8X2D Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
T46.8X2S Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
T46.8X3A Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T46.8X3D Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
T46.8X3S Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
T46.8X4A Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T46.8X4D Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
T46.8X4S Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
T46.8X6A Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela
T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.901D Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46.901S Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46.902A Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46.902D Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46.902S Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46.903A Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46.903D Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46.903S Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
T46.904A Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46.904D Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46.904S Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46.906A Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.991D Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46.991S Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46.992A Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46.992D Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46.992S Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46.993A Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46.993D Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46.993S Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
T46.994A Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46.994D Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46.994S Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
T46.996A Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela
T47.0X1A Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
T47.0X1D Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
T47.0X1S Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
T47.0X2A Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
T47.0X2D Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
T47.0X2S Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela
T47.0X3A Poisoning by histamine H2-receptor blockers, assault, initial encounter
T47.0X3D Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
T47.0X3S Poisoning by histamine H2-receptor blockers, assault, sequela
T47.0X4A Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
T47.0X4D Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
T47.0X4S Poisoning by histamine H2-receptor blockers, undetermined, sequela
T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
T47.0X6A Underdosing of histamine H2-receptor blockers, initial encounter
T47.0X6D Underdosing of histamine H2-receptor blockers, subsequent encounter
T47.0X6S Underdosing of histamine H2-receptor blockers, sequela
T47.1X1A Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
T47.1X1D Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
T47.1X1S Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
T47.1X2A Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
T47.1X2D Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
T47.1X2S Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
T47.1X3A Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
T47.1X3D Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
T47.1X3S Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
T47.1X4A Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
T47.1X4D Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
T47.1X4S Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
T47.1X6A Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
T47.1X6D Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela
T47.2X1A Poisoning by stimulant laxatives, accidental (unintentional), initial encounter
T47.2X1D Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter
T47.2X1S Poisoning by stimulant laxatives, accidental (unintentional), sequela
T47.2X2A Poisoning by stimulant laxatives, intentional self-harm, initial encounter